Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 13;10(18):4129.
doi: 10.3390/jcm10184129.

Alpha-1 Acid Glycoprotein and Podocin mRNA as Novel Biomarkers for Early Glomerular Injury in Obese Children

Anna Medyńska  1 , Joanna Chrzanowska  2 , Katarzyna Kościelska-Kasprzak  3 , Dorota Bartoszek  3 , Marcelina Żabińska  3 , Danuta Zwolińska  1
Affiliations

Alpha-1 Acid Glycoprotein and Podocin mRNA as Novel Biomarkers for Early Glomerular Injury in Obese Children

Anna Medyńska et al. J Clin Med. .

Abstract

Introduction: Obesity, which is a serious problem in children, has a negative impact on many organs, including kidneys, and obesity-related glomerulopathy (ORG) is an increasingly common cause of ESKD (end-stage kidney disease) in adults. Early-detected and -treated glomerular lesions are reversible, so it is important to find a useful marker of early damage. The study aimed to evaluate the albumin-to-creatinine ratio (ACR), urinary alpha-1-acid glycoprotein (α1-AGP), and mRNA of podocyte-specific proteins as indicators of glomerular injury and their relationship with the degree of obesity and metabolic disorders.

Materials and methods: A total of 125 obese children and 33 healthy peers were enrolled. Patients were divided into two groups, depending on SDS BMI values. ACR, α1-AGP, mRNA expression of nephrin, synaptopodin, podocin, and C2AP protein in urine sediment were measured.

Results: ACR values did not differ between groups and were within the normal range. α1-AGP and mRNA expression were significantly higher in obese children compared with controls. mRNA expression of the remaining podocyte proteins was similar in both groups. No significant differences concerning all examined parameters were found depending on the degree of obesity. There was a positive significant correlation between α1-AGP and ACR.

Conclusions: Increased α1-AGP before the onset of albuminuria suggests its usefulness as a biomarker of early glomerular damage in obese children. An increased podocin mRNA expression also indicates podocyte damage and may be linked to ORG development. The lack of increase in expression of other podocyte proteins suggests that podocin mRNA may be a more specific and sensitive biomarker. The degree of obesity has no impact on the tested parameters, but further studies are needed to confirm it.

Keywords: alpha-1 acid glycoprotein; glomerular injury; obesity; urinary mRNA expression of podocyte-associated proteins.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Wang Y., Beydoun M.A., Min J., Xue H., Kaminsky L., Cheskin L.J. Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic. Int. J. Epidemiol. 2020;49:810–823. doi: 10.1093/ije/dyz273. - DOI - PMC - PubMed
    1. World Health Organization . Obesity: Preventing and Managing the Global Epidemic. WHO Expert Consultation. WHO; Geneva, Switzerland: 2000. [(accessed on 7 November 2016)]. (Technical Report Series No. 894). Available online: http://whqlibdoc.who.int/trs/WHO_TRS_894.pdf?ua=1. - PubMed
    1. Kułaga Z., Grajda A., Gurzkowska B., Wojtyło M., Gozdz M., Litwin M. The prevalence of overweight and obesity among Polish school-aged children and adolescents. Prz. Epidemiol. 2017;70:641–651. - PubMed
    1. Rhee C., Ahmadi S.F., Kalantar-Zadeh K. The dual roles of obesity in chronic kidney disease: A review of the current literature. Curr. Opin. Nephrol. Hypertens. 2016;25:208–216. doi: 10.1097/MNH.0000000000000212. - DOI - PMC - PubMed
    1. Sandino J., Luzardo L., Morales E., Praga M. Which Patients with Obesity Are at Risk for Renal Disease? Nephron. 2021;5:1–9. doi: 10.1159/000513868. - DOI - PubMed

LinkOut - more resources